Skip to main content

Table 1 Baseline characteristics of individuals: optimal and Sub-optimal weight monitoring adherence from self-reported and diary-recorded measures

From: Self-reported recall and daily diary-recorded measures of weight monitoring adherence: associations with heart failure-related hospitalization

Characteristics Overall sample
(N = 216)
Self-reported weighing daily or more (N = 184) Self-reported weighing less than daily (N = 32) P value Diary-recorded ≥80% weighing adherence (N = 107) Diary-recorded <80% weighing adherence (N = 109) P value
Age (mean, SD) 62.2 (13.9) 62.4 (13.9) 61.1 (13.5) 0.638 64.3 (12.6) 60.1 (14.8) 0.024
Men (N, %) 103 (48) 83 (45) 20 (63) 0.069 45 (42) 58 (53) 0.101
Race/Ethnicity        
  White, Non-Hispanic 80 (37) 71 (39) 9 (28) 0.024 47 (44) 33 (30) 0.071
  Hispanic 35 (16) 24 (13) 11 (34)   12 (11) 23 (21)  
  African American 87 (40) 76 (41) 11 (34)   43 (40) 44 (40)  
  Other 14 (6) 13 (7) 1 (3)   5 (5) 9 (8)  
NYHA Class (N, %)        
  I 45 (21) 39 (21) 6 (19) 0.536 23 (21) 22 (20) 0.168
  II 111 (51) 96 (52) 15 (47)   61 (57) 50 (46)  
  III 35 (16) 27 (15) 8 (25)   15 (14) 20 (18)  
  IV 25 (12) 22 (12) 3 (9)   8 (7) 17 (16)  
Study site (N, %)        
  UNC 87 (40) 80 (43) 7 (22) <0.001a 56 (52) 31 (28) <0.001
  Northwestern University 66 (31) 62 (34) 4 (13)   33 (31) 33 (30)  
  UCSF 39 (18) 22 (12) 17 (53)   6 (6) 33 (30)  
  Olive view, UCLA 24 (11) 20 (11) 4 (13)   12 (11) 12 (11)  
Socioeconomic status, median (IQR) 4 (3, 6) 5 (3,7) 4 (1, 5) 0.026b 4 (2, 6) 4 (3, 6) 0.455b
Inadequate literacy (N, %) 74 (34) 59 (32) 15 (47) 0.103 30 (28) 44 (40) 0.06
Heart failure related QOL: Heart failure symptom scale, median (IQR) 61 (43, 79) 61(46, 79) 59 (43, 75) 0.272b 64 (46, 82) 57 (43, 71) 0.014b
Income level        
  <$15,000 101 (47) 79 (43) 22 (69) 0.052 43 (40) 58 (53) 0.098
  $15,000-$24,999 40 (19) 34 (18) 6 (19)   20 (19) 20 (18)  
  >$25,000 71 (33) 67 (36) 4 (12)   41 (38) 30 (28)  
Previous MI/Angina (N, %) 83 (38) 76 (41) 7 (22) 0.037 49 (46) 34 (31) 0.027
Systolic dysfunction (N, %) 123 (57) 112 (61) 11 (34) 0.005 65 (61) 58 (53) 0.263
ACE-Inhibitor or ARB (N, %) 178 (82) 154 (84) 24 (75) 0.233 86 (80) 92 (84) 0.437
Beta-Blocker (N, %) 176 (81) 153 (83) 23 (72) 0.130 90 (84) 86 (79) 0.324
Thiazide 22 (10) 18 (10) 4 (13) 0.750 10 (9) 12 (11) 0.823
Spironolactone 50 (23) 46 (25) 4 (13) 0.172 22 (21) 28 (25) 0.425
Telephone calls with educator, median (IQR) 16 (14, 18) 16 (15, 18) 15 (13, 16) <0.001b 17 (16, 18) 15 (13, 17) <0.001b
Self-reported weighing daily or more at baseline, (N, %) 61 (28) 58 (32) 3 (9) 0.005a 35 (33) 26 (24) 0.148
Taught weight-based diuretic self-adjustment 178 (82) 152 (83) 26 (81) 0.852 87 (81) 91 (83) 0.674
  1. aGroups compared using Fisher’s exact test.
  2. bGroups compared using both t-test and Wilcoxon-Mann–Whitney test.
  3. NYHA: New York Heart Association; MI: Myocardial Infarction; ACE: Angiotensin-Converting Enzyme; ARB: Angiotensin Receptor Blocker; IQR: Interquartile Range; QOL: Quality of Life.